Papers

7

Total Citations

473

H-Index

5

About

Lintao Cai is a pioneering researcher at the forefront of bio-inspired micro/nanorobotics and precision medicine. His work centers on developing intelligent, biocompatible micro/nanorobots that can navigate complex biological environments for targeted therapy and imaging. Cai’s major contributions include the creation of natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics (249 citations), and magnetic–acoustic sequentially actuated CAR T cell microrobots for precision navigation and in situ antitumor immunoactivation (84 citations). He has also engineered twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy (83 citations), and dual-biomineralized yeast micro/nanorobots for gastritis therapy (42 citations). His programmable ultrasound-mediated swarms of bacteria–red blood cell microrobots for tumor-specific thrombosis and photothermal therapy (12 citations) further demonstrates his innovative approach. Cai’s work has been published in top journals like *Advanced Materials*, and he is recognized for advancing the field of cell/bacteria-based bioactive materials for cancer immune modulation. With over 470 citations across his most-cited papers, Cai is shaping the future of precision medicine through bio-inspired robotics.

Research Focus

Key Achievements

5
H-Index
7
Papers
473
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics
249 citations · 2020
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago